Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A
FBIOP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$473.1M
Close$
$-3.09
120.7% downside
Current Fair Value
120.7% downsideOvervalued by 120.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $473.10 Million |
|---|---|
| Enterprise Value | $335.02 Million |
| Earnings per Share | $-0.07 |
| Beta | 1.21 |
| Outstanding Shares | 31,666,585 |
Return
| Return on Equity | 64.01% |
|---|---|
| Return on Assets | 33.17% |
| Return on Invested Capital | -15.70% |
Valuation & Multiples
| P/E Ratio | 0.59 |
|---|---|
| PEG | -0.57 |
| Price to Sales | 7.47 |
| Price to Book Ratio | 2.49 |
| Enterprise Value to Revenue | -1.09 |
| Enterprise Value to EBIT | 1.85 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | -0.79 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.20
Consensus analyst estimateRevenue Estimate
$18.30 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$-0.27
Consensus analyst estimateRevenue Estimate
$21.57 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Fortress Biotech Inc
111 employees
CEO: Lindsay Rosenwald
